Small RNA Sequencing of BRCA1/2-Mutated Ovarian Carcinomas Identifies Several miRNAs as Possible Mediators of Platinum Resistance Independent Validation of Small RNA Sequencing Findings for miR-493-5p in TCGA Dataset miR-493-5p Mediates Resistance to Platinum and PARPi in BRCA2 Mutant, but Not BRCA1 Mutant, Models In Vitro miR-493-5p Is Upregulated in a Brca2-Mutated Mammary Tumor Model with Acquired PARPi Resistance In Vivo miR-493-5p Decreases SSA in BRCA2-Mutated Cells and Does Not Rescue...
